Take Carbotor orally, once daily with a main meal to minimize gastrointestinal side effects. Swallow the tablet whole; do not crush, chew, or break it.

Carbotor selectively activates glucokinase, an enzyme crucial for glucose metabolism. By doing so, it increases the sensitivity of pancreatic beta-cells to glucose, leading to enhanced glucose-dependent insulin secretion. It also promotes glucose uptake and utilization in peripheral tissues and reduces hepatic glucose production.

• •Hypersensitivity to carbotor or any components of the formulation
• •Type 1 Diabetes Mellitus
• •Diabetic ketoacidosis
• •Severe renal impairment (CrCl <30 mL/min)
• •Severe hepatic impairment

Store in a cool, dry place, below 30°C. Protect from light and moisture. Keep out of reach of children.

Symptoms of overdose may include severe hypoglycemia, nausea, vomiting, and dizziness. In case of overdose, symptomatic and supportive measures should be initiated. Oral glucose or intravenous glucose may be administered for hypoglycemia. Gastric lavage and activated charcoal may be considered if ingestion is recent.

Limited data on Carbotor use in pregnancy. Should be used only if the potential benefit justifies the potential risk to the fetus. It is not known whether Carbotor is excreted in human milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.